Blue Trust Inc. Acquires 161 Shares of Solventum Co. (NYSE:SOLV)

Blue Trust Inc. raised its holdings in Solventum Co. (NYSE:SOLV) by 2.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 7,872 shares of the company’s stock after buying an additional 161 shares during the quarter. Blue Trust Inc.’s holdings in Solventum were worth $549,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the business. Copeland Capital Management LLC bought a new stake in Solventum in the third quarter valued at $26,000. Modus Advisors LLC purchased a new stake in shares of Solventum in the 4th quarter worth about $25,000. Mather Group LLC. bought a new stake in shares of Solventum during the 3rd quarter valued at about $27,000. True Wealth Design LLC increased its position in shares of Solventum by 23,550.0% during the third quarter. True Wealth Design LLC now owns 473 shares of the company’s stock valued at $33,000 after buying an additional 471 shares during the period. Finally, Prospera Private Wealth LLC bought a new position in Solventum in the third quarter worth about $35,000.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on SOLV. Stifel Nicolaus initiated coverage on Solventum in a research report on Tuesday, October 8th. They set a “buy” rating and a $82.00 price objective on the stock. Mizuho began coverage on Solventum in a research report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price target on the stock. Piper Sandler increased their price objective on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Finally, Morgan Stanley boosted their target price on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $68.29.

Solventum Price Performance

Solventum stock opened at $75.21 on Friday. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $96.05. The business’s fifty day simple moving average is $70.00 and its two-hundred day simple moving average is $66.98. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83.

Solventum (NYSE:SOLV) last announced its quarterly earnings data on Thursday, November 7th. The company reported $1.15 EPS for the quarter, missing the consensus estimate of $1.38 by ($0.23). The company had revenue of $2.08 billion for the quarter, compared to the consensus estimate of $2.05 billion. Equities analysts expect that Solventum Co. will post 6.58 earnings per share for the current year.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.